< style="text-align:right;text-indent:21.0pt; mso-char-indent-count:2.0;layout-grid-mode:char;mso-layout-grid-align:none"> 

Company Profiles

1.     Huadao (Shanghai) Biopharma Co., Ltd.

Huadao (Shanghai) Biopharma Co., Ltd., commonly referred to as Huadao Biopharma, is a biopharma enterprise dedicated to the advancement of cellular immunotherapy, with a special focus on pioneering innovations within the cell drug industry chain. Founded in September 2017 in Zhangjiang, Shanghai, our company’s core mission is to make cell-based medications affordable and accessible to the Chinese population. We uphold a dual path of innovation, including both the comprehensive research and development of cell drugs and the breakthroughs in industrialization through key equipment and technology. With a commitment to independent intellectual property rights, our journey over the past six years has been marked by significant milestones. We have successfully overcome pivotal challenges related to the production equipment necessary for CAR-T therapy, the development of essential disposable consumables, and the implementation of intelligent liquid nitrogen cold chain transfer for CAR-T therapies. This progress has solidified our position as a national leader in the realm of cellular immunotherapy. We bear the mantle of a national high-tech enterprise, distinguished by our independent ownership of intellectual property rights pertaining to key equipment, reagents, and consumables within the cellular immunotherapy industrial chain. Moreover, we possess the autonomy to set prices for CAR-T cell drugs. We are dedicated to evolving into a leading platform pharmaceutical company in China, as we prioritize independent innovation, research, development, production, and transformation capabilities within the realm of cell-based drugs.

2. Shanghai Graphic Design Information Co., Ltd.

Established in 2007, Shanghai Graphic Design Information Co., Ltd. boasted total assets of 578 million yuan as of 2021. With a commitment to technological excellence, we have thrived as a high-tech enterprise for an impressive 16 years as our core focus lies within the XR industry, concentrating on three major sectors: vocational and higher education, emergency safety, and high-end industry solutions. Over the years, we have served over 3,000 renowned enterprises and esteemed research institutions, including China General Nuclear Power, State Grid, PetroChina, Emerson Electric, Shanghai Airport, Huainan Mining Industry, Peking University, Tsinghua University, Zhejiang University, and the National Public Virtual Simulation Training Base for Vocational Education. Our commitment to innovation has resulted in the formation of a core technology group, wielding independent intellectual property rights in critical domains, including XR software engines, interactive tracking, motion capture, content creation, and platform development. We have actively participated in three major national special projects. We are one of the third batches of national specialized and sophisticated little giant enterprises. We earned the accolade as one of the top 100 hard technology companies in Shanghai in 2022. We won municipal-level support for dozens of scientific and technological projects. We’ve recognized as Shanghai Enterprise Technology Center, and the Shanghai Virtual Simulation Engineering Technology Research Center. Our unique value proposition has garnered significant attention from the capital market, attracting investments from over 20 institutional investors, including SAIF Asia, Haitong Securities, Bank of Nanjing, Eudel Capital, CICC, and ASD.